Of 17,095 individuals screened, a total of 550 US adults were eligible for inclusion and were categorized into either the current HFM + MO group (n = 440) or the previous HFM + MO group (n = 110) (Fig. 1). This evidence concerns the gene SF3B2 and craniofacial microsomia.